Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy

References 

1. Donegan WL. Cancer of the Breast. 3rd edn.. Philadelphia: W.B. Saunders; 1988;
2. Haagensen CD, Stout AP. Carcinoma of the breast 2 (criteria for operability). Ann. Surg. 1943;118:859–870
   • CrossRef
3. Willsher PC, Robertson JFR, Armige N, Morgan DAL, Nicholson RI, Blamey RW. Locally advanced breast cancer (long term results of a randomised trial comparing primary treatment with tamoxifen or radiotherapy). Eur. J. Surg. Oncol. 1996;22:33–37
4. Rubens RD, Bartelink H, Englesman E, et al.  Local advanced breast cancer (the contribution of cytotoxic and endocrine treatment to radiotherapy). Eur. J. Cancer Clin. Oncol. 1989;25:667–678
   • MEDLINE
   • CrossRef
5. Willsher PC, Robertson JFR, Chan SY, Jackson L, Blamey RW. Locally advance breast cancer (early results of a randomised trial of multimodal therapy versus initial hormone therapy). Eur. J. Cancer. 1997;33:45–49
   • Abstract
   • Full-Text PDF (615 KB)
   • CrossRef
6. Hayward JL, Carbone PP, Heuson JC, Kumaoka S, Rubens R. Assessment of response to therapy in advanced breast cancer (a project of the Programme on Clinical Oncology of the International union Against Cancer, Geneva, Switzerland). Cancer. 1977;39:1289–1294
   • CrossRef
7. British Breast Group . Assessment of response to treatment in advanced breast cancer. Lancet. 1974;3:38–39
8. Snead DRJ, Bell JA, Dixon AR, et al.  Methodology of immunohistological detection of estrogen receptor in human breast carcinoma in formalin-fixed, paraffin-embedded tissue (a comparison with frozen section methodology). Histopathology. 1993;23:223–238
9. Hortobagyi GN. Multidisciplinary management of advanced primary and metastatic breast cancer. Cancer. 1994;74:416–423
   • CrossRef
10. Gazet JC, Ford HT, Coombes RC. Randomised trial of chemotherapy versus endocrine therapy in patients presenting locally advanced breast cancer (a pilot study). Br. J. Cancer. 1991;63:279–282
    • MEDLINE
11. Smith IE, Jones AL, O'Brien ME, McKinna JA, Sacks N, Baum M. Primary medical (neoadjuvant) chemotherapy for operable breast cancer. Eur. J. Cancer. 1993;29A:1796–1799
    • MEDLINE
12. Veronesi A, Frustaci S, Tirelli U, et al.  Tamoxifen therapy in postmenopausal advanced breast cancer (efficacy at the primary tumor site in 46 evaluable patients). Tumori. 1981;67:235–238
    • MEDLINE
13. Anderson EDC, Forrest APM, Levak PA, Chetty U, Hawkins RA. Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer. Br. J. Cancer. 1989;60:223–226
    • MEDLINE
14. Ahern V, Barraclough B, Bosch C, Langlands A, Boyages J. Locally advanced breast cancer (definig an optimum treatment). Internat. J. Rad. Oncol., Bio., Phy. 1994;28:867–875
15. Mustacchi G, Latteier J, Baum M, et al.  Tamoxifen alone versus surgery plus tamoxifen for breast cancer of the elderly. Meta-analysis of long term results of the GRETA and CRC trials. Breast Cancer Res. Treat. 1998;50:227
    • MEDLINE
16. Kantarjian HM, Hortobagyi GN, Smith TL, et al.  The management of locally advanced breast cancer (a combined modality approach). Eur. J. Cancer Clin. Oncol. 1984;20:1353–1361
    • MEDLINE
    • CrossRef
17. De Mattels A, Montella M, Iannuzzo M, et al.  Multimodal treatment strategy for locally advanced breast cancer. J Chemother. 1998;10:476–483
18. Begg C, Cho M, Eastwood S, et al.  Improving the quality of reporting of randomised controlled trials (the CONSORT statement). JAMA. 1996;276:637–639
    • MEDLINE